METHODS AND COMPOSITIONS FOR IDENTIFYING PROSTATE CANCER OR A HUMORAL IMMUNE RESPONSE AGAINST PROSTATE CANCER

The present invention relates to prostate cancer markers, compositions comprising such markers, immunoglobulins specific for such markers, and methods of using such markers and/or immunoglobulins to assess an immune response against prostate cancer. An immune response against the markers correlates...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HARDING, THOMAS, KOPRIVNIKAR, KATHRYN E, JOOSS, KARIN, NGUYEN, MINH
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY COMBINATORIAL CHEMISTRY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICOLIBRARIES MEASURING METALLURGY PHYSICS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to prostate cancer markers, compositions comprising such markers, immunoglobulins specific for such markers, and methods of using such markers and/or immunoglobulins to assess an immune response against prostate cancer. An immune response against the markers correlates with an immune response, in particular a humoral immune response, against prostate cancer cells which immune response is preferably associated with prophylaxis of prostate cancer, treatment of prostate cancer, and/or amelioration of at least one symptom associated with prostate cancer. Cette invention concerne des marqueurs du cancer de la prostate, des compositions comprenant de tels marqueurs, des immunoglobines spécifiques de tels marqueurs et des procédés consistant à utiliser ces marqueurs et/ou des immunoglobulines pour évaluer une réponse immune contre le cancer de la prostate. Une réponse immune contre les marqueurs se corrèle avec une réponse immune, en particulier, une réponse immune humorale contre des cellules du cancer de la prostate dont la réponse immune est de préférence associée à la prophylaxie du cancer de la prostate.